A new schedule of mitomycin-C and vinorelbine combination in patients with metastatic breast cancer (MBC) resistant to anthracyclines and taxanes: A phase II study.
Proceedings of European Society of Clinical Oncology, 18 - 22 Ekim 2002, (Özet Bildiri)
- Yayın Türü: Bildiri / Özet Bildiri
- Gazi Üniversitesi Adresli: Evet